Clinical trial
Investigation of the Triglyceride/Glucose Index in Diabetic Patients Using SGLT-2 Inhibitor
NCT05915884 is registered in ClinicalTrials.gov with Samsun Education and Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of the Triglyceride/Glucose Index in Diabetic Patients Using SGLT-2 Inhibitor
- Lead sponsor
- Samsun Education and Research Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 10, 2023
- Completion date
- January 28, 2024
- Enrollment
- 55 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes, metabolic disease